Chemoradiotherapeutic wrinkled mesoporous silica nanoparticles for use in cancer therapy

• Main Authors: Imalka Munaweera, Bhuvaneswari Koneru, Yi Shi, Anthony J. Di Pasqua, Kenneth J. Balkus, Jr.
• Format: Article
• Language: English
• Published: AIP Publishing LLC 2014-11-01
• Series: APL Materials
• Online Access: http://dx.doi.org/10.1063/1.4899118

Over the last decade, the development and application of nanotechnology in cancer detection, diagnosis, and therapy have been widely reported. Engineering of vehicles for the simultaneous delivery of chemo- and radiotherapeutics increases the effectiveness of the therapy and reduces the dosage of each individual drug required to produce an observable therapeutic response. We here developed a novel chemoradiotherapeutic 1,2-dioleoyl-sn-glycero-3-phosphocholine lipid coated/uncoated platinum drug loaded, holmium-containing, wrinkled mesoporous silica nanoparticle. The materials were characterized with TEM, FTIR, 1H NMR, energy dispersive x-ray, inductively coupled plasma-mass spectrometry, and zeta potential measurements. In vitro platinum drug release from both lipid coated and uncoated chemoradiotherapeutic wrinkled mesoporous silica are reported. Various kinetic models were used to analyze the release kinetics. The radioactivity of the chemoradiotherapeutic nanocarriers was measured after neutron-activation.